ACLS

Axcelis Technologies, Inc.

Fundamental data last updated:May 16, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Technology

industry

Semiconductors

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

08/04/2026

Business Summary

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

 


Analyze ACLS on TradingView

VALUATION

P/E

49.23

Market Cap ($M USD)

$4.97B

Forward P/E

32.26

PEG

0.61

PRICE TO SALES

5.88

PRICE TO BOOK

4.75

EV / EBITDA

36.38

5-Year Average P/E

Free Cash Flow Yield

1.78%

DCF Value

$61.26

Graham Number

$50.12

Price to FCF

56.15

EV to FCF

54.92

Earnings Yield

2.03%

FCF Yield

1.78%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$3.28

Next Year EPS Growth Estimate

$5.01

Next Year Revenue Growth Estimate

$103.00B

Return on Equity (ROE)

9.79%

FREE CASH FLOW

Operating Margin

11.60%

Debt-to-Equity

0.04

Piotroski F-Score

4

Altman Z-Score

11.09

Return on Invested Capital (ROIC)

8.38%

Current Ratio

4.59

Quick Ratio

2.99

Net Debt to EBITDA

-0.82

Interest Coverage

24.63

Gross Profit margin

43.61%

FCF PER SHARE

$2.88

REVENUE PER SHARE

$27.52

Analyze ACLS on TradingView

Gainseekers Quantitative Analysis

Summary

ACLS appears to be priced for perfection, with its snapshot price extended far above its DCF value and Graham Number. The Forward P/E of 32.54 suggests optimism about future earnings, yet the earnings yield of just 2.01% indicates limited immediate return. However, the Altman Z-score of 11.10 signals robust financial health, suggesting low bankruptcy risk. Despite these strengths, the market may be overestimating growth potential relative to intrinsic value.

AI Exposure / Tech Reliance

In the rapidly evolving semiconductor industry, Axcelis Technologies is well-positioned to capitalize on AI advancements. As a player in a sector critical to tech infrastructure, it stands to benefit from increased demand for advanced chips. This positioning could drive future growth as AI integration becomes more pervasive.

The Bull Case

For the discerning GARP investor, ACLS offers compelling reasons to buy. The ROIC of 8.38% reflects efficient capital use, while a low debt/equity ratio of 0.04 underscores financial prudence. Despite a modest FCF yield of 1.80%, the company's operating margin of 11.60% and a Piotroski F-Score of 4 suggest solid operational execution. These metrics hint at strong pricing power and a resilient business model.

The Bear Case

Yet, the stock is not without its pitfalls. Valuation multiples like Price/Sales at 5.93 and Price/Book at 4.79 are steep, indicating potential overvaluation. The EV to EBITDA ratio of 37.96 further highlights this concern. With the stock trading close to its 52-week high, technical overextension is a real risk. Additionally, a low earnings yield and high Price to FCF ratio of 55.47 suggest that cash flow generation may not justify the current price levels.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$128.00

Institutional Ownership %

1-Year Beta

1.92

Insider Buying % (6 Mo)

Distance to 52-Week High

6.17%

Distance to 52-Week Low

65.40%

EARNINGS SURPRISE %

1.41%

50-DAY SMA

$115.27

200-DAY SMA

$92.67

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.